Skip to main content
. Author manuscript; available in PMC: 2019 Jan 1.
Published in final edited form as: J Infect. 2017 Oct 20;76(1):44–54. doi: 10.1016/j.jinf.2017.10.007

Figure 1.

Figure 1

TB treatment and outcomes over time among 105 patients with MDR-TB (left), 183 with no DST (middle) and 130 patients with susceptible TB (right) from time of start of TB treatment.

R = Rifampicin

H = Isoniazid

Z = Pyrazinamide

E = Ethambutol

S = Streptomycin

FQ = Fluoroquinolone

2L-inj = Second-line injectables

LTFU = Loss to follow-up

DST = Drug-susceptibility test